参附合香丹注射液治疗肺心病急性发作期合并心力衰竭临床研究  

Clinical Study on Shenfu Injection(参附注射液) and Xiangdan Injection(香丹注射液) for Pulmonary Heart Disease Associated with Congestive Heart Failure in Actute Episode Period

作　　者：贺运河[1] 陈镜合[1] 陈世伟[2] 胡彬文[1] 

机构地区：[1]广州中医药大学第一附属医院,广州510405 [2]广东省深圳市罗湖区人民医院,深圳518004

出　　处：《中国中医急症》2004年第1期21-22,共2页Journal of Emergency in Traditional Chinese Medicine

摘　　要：目的观察参附合香丹注射液治疗肺心病急性发作期合并心力衰竭的疗效。方法将患者70例随机分为两组,对照组35例予西医常规治疗,治疗组35例在此基础上静滴参附和香丹注射液。结果治疗组总有效率及在降低肿瘤坏死因子、升高动脉血氧分压、降低二氧化碳分压、改善血液流变学指标等方面明显优于对照组。结论肺心病急性发作期合并心衰患者在西医常规治疗基础上加用参附和香丹注射液治疗,其疗效优于单纯西医常规治疗者。To observe the therapeatic effects of Shenfu Injection and Xiangdan Injection for pulmonary heart disease associated congestive heart failure in acute episode period.Methods:70 patients were divided randomly into the treatment group (treated with Shenfu Injection and Xiangdan Injection,and routine treatment) and the controlled group (treated with routine treatment only).Results:The treatment group was supior to controlled group in the general effective rate and the indexes of reducing tumor necrosis factor (TNF- α ),improving partial pressure of arterial oxy(PaO2),decreasing partial pressure of carbonxide(PaCO2) and amelioration hemorheology marker.Conclusion:Shenfu Injection,Xiangdan Injection and routine treatment administered together are better than routine treatment only in treatment of pulmonary heart disease associated heart failure.

关 键 词：参附注射液 香丹注射液 肺心病 急性发作期 合并症 心力衰竭 临床研究 

分 类 号：R259.415[医药卫生—中西医结合]